NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Australia's Sonic Healthcare to buy U.S.-based Aurora Diagnostics for $540 mln

Published 12/12/2018, 08:34 am
Updated 12/12/2018, 08:40 am
© Reuters.  Australia's Sonic Healthcare to buy U.S.-based Aurora Diagnostics for $540 mln
SHL
-

Dec 12 (Reuters) - Australian pathology and radiology group Sonic Healthcare Ltd SHL.AX said on Wednesday it had agreed to buy Florida-based Aurora Diagnostics LLC for $540 million.

The acquisition of Aurora is expected to be about three percent EPS accretive post-placement on a pro-forma FY2019 basis before expected revenue and cost synergies, Sonic said in a statement.

The acquisition, Sonic said, would help it "substantially grow" its operations in the United States.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.